ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 57,868 Value ($000) $891 Avg Close $19.92 Range $15.14 - $24.64
Q3 2025
Shares 79,508 Value ($000) $1,628 Avg Close $20.16 Range $17.43 - $24.38
Q2 2025
Shares 138,280 Value ($000) $2,774 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 70,436 Value ($000) $1,386 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 87,188 Value ($000) $1,962 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 27,682 Value ($000) $707 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 20,118 Value ($000) $470 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 26,835 Value ($000) $472 Avg Close $15.34 Range $10.90 - $19.50
Q3 2023
Shares 105 Value ($000) $1 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 81 Value ($000) $2 Avg Close $20.21 Range $17.15 - $23.98
Q1 2023
Shares 334 Value ($000) $7 Avg Close $20.34 Range $14.56 - $25.34